Three-antigen target combined new crown recombinant NDV (Newcastle Disease Virus) vector as well as corresponding vaccine strain and vaccine

The invention discloses a new crown recombinant NDV (Newcastle Disease Virus) vector combined with three antigen targets as well as a corresponding vaccine strain and a vaccine. The recombinant NDV vector comprises a coding nucleotide sequence of a novel coronavirus S recombinant protein and coding...

Ausführliche Beschreibung

Gespeichert in:
Bibliographische Detailangaben
Hauptverfasser: CHEN RUITING, SONG JIASHENG, JIAN SHULING, MAO SHUIHUA, SUN HUIMIN, FANG CHENJIE, ZHOU MENGYUN, WU XIAOYAN
Format: Patent
Sprache:chi ; eng
Schlagworte:
Online-Zugang:Volltext bestellen
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
container_end_page
container_issue
container_start_page
container_title
container_volume
creator CHEN RUITING
SONG JIASHENG
JIAN SHULING
MAO SHUIHUA
SUN HUIMIN
FANG CHENJIE
ZHOU MENGYUN
WU XIAOYAN
description The invention discloses a new crown recombinant NDV (Newcastle Disease Virus) vector combined with three antigen targets as well as a corresponding vaccine strain and a vaccine. The recombinant NDV vector comprises a coding nucleotide sequence of a novel coronavirus S recombinant protein and coding nucleotide sequences of two novel coronavirus RBD recombinant proteins, the coding nucleotide sequence of the novel coronavirus S recombinant protein is inserted between the P gene and the M gene of the NDV vector; the coding nucleotide sequences of the two novel coronavirus RBD recombinant proteins are respectively inserted between the P gene and the M gene of the NDV vector and between the M gene and the F gene of the NDV vector. Compared with a vaccine formed by a double-target combined new crown recombinant NDV (Newcastle Disease Virus) vector, the vaccine provided by the invention has higher immunogenicity and wider-spectrum protection capability. 本发明公开了一种三抗原靶标结合的新冠重组NDV载体及相应的疫苗株和疫苗,所述重组NDV载体包括:一个新型冠状病毒S重组蛋白的编
format Patent
fullrecord <record><control><sourceid>epo_EVB</sourceid><recordid>TN_cdi_epo_espacenet_CN117487858A</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><sourcerecordid>CN117487858A</sourcerecordid><originalsourceid>FETCH-epo_espacenet_CN117487858A3</originalsourceid><addsrcrecordid>eNqNjLEOgkAQBWksjPoPa6cFBVEDrUGNFRWhNevxxEtwj-yd8hN-tBi1t5pkMplx9CyvCsQswTYQCqwNAhl3O1tBTYKejLpeSPGRQ0nFrqJFgd6wDy1oZz3Ygyqrd7-kB0xwSuypR9u-aZwqfOekttLQg40Z5uSDshViqX9qGo0u3HrMvpxE88O-zI8xOncaBmwgCKe8SJJ0naXZJtuu_mleyS1NRQ</addsrcrecordid><sourcetype>Open Access Repository</sourcetype><iscdi>true</iscdi><recordtype>patent</recordtype></control><display><type>patent</type><title>Three-antigen target combined new crown recombinant NDV (Newcastle Disease Virus) vector as well as corresponding vaccine strain and vaccine</title><source>esp@cenet</source><creator>CHEN RUITING ; SONG JIASHENG ; JIAN SHULING ; MAO SHUIHUA ; SUN HUIMIN ; FANG CHENJIE ; ZHOU MENGYUN ; WU XIAOYAN</creator><creatorcontrib>CHEN RUITING ; SONG JIASHENG ; JIAN SHULING ; MAO SHUIHUA ; SUN HUIMIN ; FANG CHENJIE ; ZHOU MENGYUN ; WU XIAOYAN</creatorcontrib><description>The invention discloses a new crown recombinant NDV (Newcastle Disease Virus) vector combined with three antigen targets as well as a corresponding vaccine strain and a vaccine. The recombinant NDV vector comprises a coding nucleotide sequence of a novel coronavirus S recombinant protein and coding nucleotide sequences of two novel coronavirus RBD recombinant proteins, the coding nucleotide sequence of the novel coronavirus S recombinant protein is inserted between the P gene and the M gene of the NDV vector; the coding nucleotide sequences of the two novel coronavirus RBD recombinant proteins are respectively inserted between the P gene and the M gene of the NDV vector and between the M gene and the F gene of the NDV vector. Compared with a vaccine formed by a double-target combined new crown recombinant NDV (Newcastle Disease Virus) vector, the vaccine provided by the invention has higher immunogenicity and wider-spectrum protection capability. 本发明公开了一种三抗原靶标结合的新冠重组NDV载体及相应的疫苗株和疫苗,所述重组NDV载体包括:一个新型冠状病毒S重组蛋白的编</description><language>chi ; eng</language><subject>BEER ; BIOCHEMISTRY ; CHEMISTRY ; COMPOSITIONS THEREOF ; CULTURE MEDIA ; ENZYMOLOGY ; HUMAN NECESSITIES ; HYGIENE ; MEDICAL OR VETERINARY SCIENCE ; METALLURGY ; MICROBIOLOGY ; MICROORGANISMS OR ENZYMES ; MUTATION OR GENETIC ENGINEERING ; ORGANIC CHEMISTRY ; PEPTIDES ; PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES ; PROPAGATING, PRESERVING OR MAINTAINING MICROORGANISMS ; SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS ORMEDICINAL PREPARATIONS ; SPIRITS ; VINEGAR ; WINE</subject><creationdate>2024</creationdate><oa>free_for_read</oa><woscitedreferencessubscribed>false</woscitedreferencessubscribed></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><linktohtml>$$Uhttps://worldwide.espacenet.com/publicationDetails/biblio?FT=D&amp;date=20240202&amp;DB=EPODOC&amp;CC=CN&amp;NR=117487858A$$EHTML$$P50$$Gepo$$Hfree_for_read</linktohtml><link.rule.ids>230,308,778,883,25551,76304</link.rule.ids><linktorsrc>$$Uhttps://worldwide.espacenet.com/publicationDetails/biblio?FT=D&amp;date=20240202&amp;DB=EPODOC&amp;CC=CN&amp;NR=117487858A$$EView_record_in_European_Patent_Office$$FView_record_in_$$GEuropean_Patent_Office$$Hfree_for_read</linktorsrc></links><search><creatorcontrib>CHEN RUITING</creatorcontrib><creatorcontrib>SONG JIASHENG</creatorcontrib><creatorcontrib>JIAN SHULING</creatorcontrib><creatorcontrib>MAO SHUIHUA</creatorcontrib><creatorcontrib>SUN HUIMIN</creatorcontrib><creatorcontrib>FANG CHENJIE</creatorcontrib><creatorcontrib>ZHOU MENGYUN</creatorcontrib><creatorcontrib>WU XIAOYAN</creatorcontrib><title>Three-antigen target combined new crown recombinant NDV (Newcastle Disease Virus) vector as well as corresponding vaccine strain and vaccine</title><description>The invention discloses a new crown recombinant NDV (Newcastle Disease Virus) vector combined with three antigen targets as well as a corresponding vaccine strain and a vaccine. The recombinant NDV vector comprises a coding nucleotide sequence of a novel coronavirus S recombinant protein and coding nucleotide sequences of two novel coronavirus RBD recombinant proteins, the coding nucleotide sequence of the novel coronavirus S recombinant protein is inserted between the P gene and the M gene of the NDV vector; the coding nucleotide sequences of the two novel coronavirus RBD recombinant proteins are respectively inserted between the P gene and the M gene of the NDV vector and between the M gene and the F gene of the NDV vector. Compared with a vaccine formed by a double-target combined new crown recombinant NDV (Newcastle Disease Virus) vector, the vaccine provided by the invention has higher immunogenicity and wider-spectrum protection capability. 本发明公开了一种三抗原靶标结合的新冠重组NDV载体及相应的疫苗株和疫苗,所述重组NDV载体包括:一个新型冠状病毒S重组蛋白的编</description><subject>BEER</subject><subject>BIOCHEMISTRY</subject><subject>CHEMISTRY</subject><subject>COMPOSITIONS THEREOF</subject><subject>CULTURE MEDIA</subject><subject>ENZYMOLOGY</subject><subject>HUMAN NECESSITIES</subject><subject>HYGIENE</subject><subject>MEDICAL OR VETERINARY SCIENCE</subject><subject>METALLURGY</subject><subject>MICROBIOLOGY</subject><subject>MICROORGANISMS OR ENZYMES</subject><subject>MUTATION OR GENETIC ENGINEERING</subject><subject>ORGANIC CHEMISTRY</subject><subject>PEPTIDES</subject><subject>PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES</subject><subject>PROPAGATING, PRESERVING OR MAINTAINING MICROORGANISMS</subject><subject>SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS ORMEDICINAL PREPARATIONS</subject><subject>SPIRITS</subject><subject>VINEGAR</subject><subject>WINE</subject><fulltext>true</fulltext><rsrctype>patent</rsrctype><creationdate>2024</creationdate><recordtype>patent</recordtype><sourceid>EVB</sourceid><recordid>eNqNjLEOgkAQBWksjPoPa6cFBVEDrUGNFRWhNevxxEtwj-yd8hN-tBi1t5pkMplx9CyvCsQswTYQCqwNAhl3O1tBTYKejLpeSPGRQ0nFrqJFgd6wDy1oZz3Ygyqrd7-kB0xwSuypR9u-aZwqfOekttLQg40Z5uSDshViqX9qGo0u3HrMvpxE88O-zI8xOncaBmwgCKe8SJJ0naXZJtuu_mleyS1NRQ</recordid><startdate>20240202</startdate><enddate>20240202</enddate><creator>CHEN RUITING</creator><creator>SONG JIASHENG</creator><creator>JIAN SHULING</creator><creator>MAO SHUIHUA</creator><creator>SUN HUIMIN</creator><creator>FANG CHENJIE</creator><creator>ZHOU MENGYUN</creator><creator>WU XIAOYAN</creator><scope>EVB</scope></search><sort><creationdate>20240202</creationdate><title>Three-antigen target combined new crown recombinant NDV (Newcastle Disease Virus) vector as well as corresponding vaccine strain and vaccine</title><author>CHEN RUITING ; SONG JIASHENG ; JIAN SHULING ; MAO SHUIHUA ; SUN HUIMIN ; FANG CHENJIE ; ZHOU MENGYUN ; WU XIAOYAN</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-epo_espacenet_CN117487858A3</frbrgroupid><rsrctype>patents</rsrctype><prefilter>patents</prefilter><language>chi ; eng</language><creationdate>2024</creationdate><topic>BEER</topic><topic>BIOCHEMISTRY</topic><topic>CHEMISTRY</topic><topic>COMPOSITIONS THEREOF</topic><topic>CULTURE MEDIA</topic><topic>ENZYMOLOGY</topic><topic>HUMAN NECESSITIES</topic><topic>HYGIENE</topic><topic>MEDICAL OR VETERINARY SCIENCE</topic><topic>METALLURGY</topic><topic>MICROBIOLOGY</topic><topic>MICROORGANISMS OR ENZYMES</topic><topic>MUTATION OR GENETIC ENGINEERING</topic><topic>ORGANIC CHEMISTRY</topic><topic>PEPTIDES</topic><topic>PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES</topic><topic>PROPAGATING, PRESERVING OR MAINTAINING MICROORGANISMS</topic><topic>SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS ORMEDICINAL PREPARATIONS</topic><topic>SPIRITS</topic><topic>VINEGAR</topic><topic>WINE</topic><toplevel>online_resources</toplevel><creatorcontrib>CHEN RUITING</creatorcontrib><creatorcontrib>SONG JIASHENG</creatorcontrib><creatorcontrib>JIAN SHULING</creatorcontrib><creatorcontrib>MAO SHUIHUA</creatorcontrib><creatorcontrib>SUN HUIMIN</creatorcontrib><creatorcontrib>FANG CHENJIE</creatorcontrib><creatorcontrib>ZHOU MENGYUN</creatorcontrib><creatorcontrib>WU XIAOYAN</creatorcontrib><collection>esp@cenet</collection></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext_linktorsrc</fulltext></delivery><addata><au>CHEN RUITING</au><au>SONG JIASHENG</au><au>JIAN SHULING</au><au>MAO SHUIHUA</au><au>SUN HUIMIN</au><au>FANG CHENJIE</au><au>ZHOU MENGYUN</au><au>WU XIAOYAN</au><format>patent</format><genre>patent</genre><ristype>GEN</ristype><title>Three-antigen target combined new crown recombinant NDV (Newcastle Disease Virus) vector as well as corresponding vaccine strain and vaccine</title><date>2024-02-02</date><risdate>2024</risdate><abstract>The invention discloses a new crown recombinant NDV (Newcastle Disease Virus) vector combined with three antigen targets as well as a corresponding vaccine strain and a vaccine. The recombinant NDV vector comprises a coding nucleotide sequence of a novel coronavirus S recombinant protein and coding nucleotide sequences of two novel coronavirus RBD recombinant proteins, the coding nucleotide sequence of the novel coronavirus S recombinant protein is inserted between the P gene and the M gene of the NDV vector; the coding nucleotide sequences of the two novel coronavirus RBD recombinant proteins are respectively inserted between the P gene and the M gene of the NDV vector and between the M gene and the F gene of the NDV vector. Compared with a vaccine formed by a double-target combined new crown recombinant NDV (Newcastle Disease Virus) vector, the vaccine provided by the invention has higher immunogenicity and wider-spectrum protection capability. 本发明公开了一种三抗原靶标结合的新冠重组NDV载体及相应的疫苗株和疫苗,所述重组NDV载体包括:一个新型冠状病毒S重组蛋白的编</abstract><oa>free_for_read</oa></addata></record>
fulltext fulltext_linktorsrc
identifier
ispartof
issn
language chi ; eng
recordid cdi_epo_espacenet_CN117487858A
source esp@cenet
subjects BEER
BIOCHEMISTRY
CHEMISTRY
COMPOSITIONS THEREOF
CULTURE MEDIA
ENZYMOLOGY
HUMAN NECESSITIES
HYGIENE
MEDICAL OR VETERINARY SCIENCE
METALLURGY
MICROBIOLOGY
MICROORGANISMS OR ENZYMES
MUTATION OR GENETIC ENGINEERING
ORGANIC CHEMISTRY
PEPTIDES
PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
PROPAGATING, PRESERVING OR MAINTAINING MICROORGANISMS
SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS ORMEDICINAL PREPARATIONS
SPIRITS
VINEGAR
WINE
title Three-antigen target combined new crown recombinant NDV (Newcastle Disease Virus) vector as well as corresponding vaccine strain and vaccine
url https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-01-15T11%3A09%3A34IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-epo_EVB&rft_val_fmt=info:ofi/fmt:kev:mtx:patent&rft.genre=patent&rft.au=CHEN%20RUITING&rft.date=2024-02-02&rft_id=info:doi/&rft_dat=%3Cepo_EVB%3ECN117487858A%3C/epo_EVB%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_id=info:pmid/&rfr_iscdi=true